Drug Profile
Angiostatic cocktail - Angiogen
Latest Information Update: 20 Mar 2014
Price :
$50
*
At a glance
- Originator Angiogen LLC
- Developer Angiogen
- Class
- Mechanism of Action Angiogenesis inhibitors; Plasminogen activators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 07 Apr 2006 Phase-I clinical trials in Solid tumours in USA (unspecified route)